Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|April 29, 2006
Esophageal carcinosarcoma with intramural metastasisY Sanada, J Hihara, K Yoshida, et al.[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai|March 1, 1993
[A case of solitary plasmacytoma that originated in a rib]J Hihara, S Takeo, M Furuyama, et al.Anticancer Research|June 16, 1999
Down-regulation of IL-10 enhances the efficacy of locoregional immunotherapy using OK-432 against malignant effusionJ Hihara, Y Yamaguchi, K Minami, et al.Journal of Experimental Therapeutics & Oncology|July 1, 1996
Profile of T-cell receptor V beta gene usage of cytotoxic T cells induced by intrapleural administration of a streptococcal preparation, OK432, in malignant effusionsE Miyahara, Y Yamaguchi, J Hihara, et al.Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|March 12, 2014
Effects of neoadjuvant chemoradiotherapy on postoperative morbidity and mortality associated with esophageal cancerY Hamai, J Hihara, J Taomoto, et al.Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|February 24, 2001
Significance of lymph node dissection of the superior mediastinal region in esophageal cancer patientsT Hirai, J Hihara, M Inoue, et al.Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|March 11, 1999
Clinical results of transhiatal esophagectomy for carcinoma of the lower thoracic esophagus according to biological markersT Hirai, M Kuwahara, K Yoshida, et al.Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|October 17, 2015
Role of definitive chemoradiotherapy using docetaxel and 5-fluorouracil in patients with unresectable locally advanced esophageal squamous cell carcinoma: a phase II studyJ Hihara, Y Hamai, M Emi, et al.Anticancer Research|April 13, 2001
Generation of cytotoxic effector lymphocytes by MLTC using tumor cells genetically modified to secrete interleukin-2Y Yamaguchi, K Ohta, K Shimizu, et al.Anticancer Research|March 4, 2000
Immunological properties of tumor cells genetically modified to secrete interleukin-2I Takashima, Y Yamaguchi, T Yorishima, et al.Pageof 3